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Abstract
Background: A genetically-engineered strain of the dengue mosquito vector Aedes aegypti, designated OX3604C, was
evaluated in large outdoor cage trials for its potential to improve dengue prevention efforts by inducing population
suppression. OX3604C is engineered with a repressible genetic construct that causes a female-specific flightless phenotype.
Wild-type females that mate with homozygous OX3604C males will not produce reproductive female offspring. Weekly
introductions of OX3604C males eliminated all three targeted Ae. aegypti populations after 10–20 weeks in a previous
laboratory cage experiment. As part of the phased, progressive evaluation of this technology, we carried out an assessment
in large outdoor field enclosures in dengue endemic southern Mexico.
Methodology/Principal Findings: OX3604C males were introduced weekly into field cages containing stable target
populations, initially at 10:1 ratios. Statistically significant target population decreases were detected in 4 of 5 treatment
cages after 17 weeks, but none of the treatment populations were eliminated. Mating competitiveness experiments, carried
out to explore the discrepancy between lab and field cage results revealed a maximum mating disadvantage of up 59.1%
for OX3604C males, which accounted for a significant part of the 97% fitness cost predicted by a mathematical model to be
necessary to produce the field cage results.
Conclusions/Significance: Our results indicate that OX3604C may not be effective in large-scale releases. A strain with the
same transgene that is not encumbered by a large mating disadvantage, however, could have improved prospects for
dengue prevention. Insights from large outdoor cage experiments may provide an important part of the progressive,
stepwise evaluation of genetically-engineered mosquitoes.
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Introduction
The recent worldwide increase in dengue [1,2] has made urgent the
development and assessment of new tools for controlling the disease
[3]. Because no vaccines or drugs are commercially available [4,5],
mosquito vector control by insecticides, insect growth regulators and
larval development site elimination (source reduction) are the current
means for dengue prevention [6]. Long-term control of Aedes aegypti,
the most efficient dengue vector [7], is a challenging and expensive
task that is difficult to achieve and maintain, especially in developing,
resource-challenged environments [8–10]. Genetically-engineered
(GE) Ae. aegypti strains that are unable to transmit dengue [11] or
that bear sterility genes [12,13] constitute new tools to control dengue
and merit confined experimental evaluation while public and scientific
discourse enables appropriate oversight of this new technology
[14,15]. Concern regarding the use of GE organisms, and the
absence of guidelines to help researchers interact with local
communities, motivated the elaboration of a framework for the
development, evaluation, and application of genetic strategies for
prevention of mosquito-borne disease [16]. These guidelines were
followed carefully in the development and execution of the
experiments described here.
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The OX3604C strain of Ae. aegypti contains a tetracycline-
regulated transgene that induces a female-specific flightless
phenotype that cannot reproduce as a consequence of its inability
to fly and mate [17]. Tetracycline is added to larval rearing water
to allow normal female development during colony maintenance
and amplification, but is not added during the generation used
for mass-production of males. This enables genetic removal of
females, because females carrying the transgene and reared in the
absence of tetracycline cannot fly. Similarly, female offspring that
result from matings between wild-type females and released
OX3604C males are unable to fly or reproduce. The goal in
releasing OX3604C males is to control dengue virus transmission
by reducing or eliminating Ae. aegypti populations. The release of
insects carrying a dominant female-lethal construct has four main
advantages compared to a traditional sterile insect technique
(SIT): (i) no need to sort males and females, (ii) no need for facilities
to irradiate males, (iii) the transgene has an effect in subsequent
generations because it is dominant and inherited by male
offspring, and (iv) OX3604C contains a heritable, fluorescent
marker (DsRed2) that distinguishes it from immature wild-type
Ae. aegypti [17].
As an initial step in OX3604C evaluation, transgenic males
were introduced weekly at an 8.5–10:1 OX3604C:target ratio into
large laboratory cages with constant temperature, humidity, and
photoperiod, that contained stable target populations of wild type
Ae. aegypti [18]. Target populations were eliminated in all
experimental cages in 10–20 weeks, supporting further analyses
of this strain in contained or confined field trials to evaluate mating
competitiveness and environmental and other effects on its
performance [18].
Progressive evaluation of OX3604C from laboratory to field
cages prior to open field release is valuable because it allows
for systematic assessment of possible environmental effects on
mosquito performance under conditions increasingly more natu-
ral. Comparison of transgenic mosquito performance in laboratory
versus semi-field conditions is expected to provide valuable data
for planning subsequent experimental assessments and refine
strategies for disease prevention. Insectary studies in a laboratory,
field cage experiments and deliberative community engagement
activities are all part of the progressive transition of engineered
insects from the laboratory to open field releases [19,20]. This is
particularly true when the transgene as well as all other genes in
the transgenic strain can be introduced into natural target
populations and transmitted to subsequent generations. Even
though OX3604C is a self-limiting strategy that lacks a gene drive
component, it can introduce through heterozygous males new
alleles and genes into target populations.
We report the effect of OX3604C in reducing target Ae. aegypti
populations in the first large outdoor field cage trial of a transgenic
population suppression tool. While density reduction was signif-
icant in four of five target populations, we did not observe
population elimination in any of the cages within the time
expected. A series of subsequent experiments revealed a significant
mating disadvantage for OX3604C males that was not observed in
the laboratory study. We discuss the implications of our results for




Our study was carried out on a plot of land (14u519410N,
292u219150W) referred to hereafter as the ‘‘field site.’’ The land
was a 4.5 ha flat, rural area located 11.2 km southeast of the
center of Tapachula, Mexico, in the village of El Zapote (Ejido Rio
Florido). The study area is characterized by a tropical climate with
a rainy season from May to October (average total rainfall of
2,100 mm) and a dry season from November to April (average
total rainfall of 50 mm). Supportive laboratory and insectary
facilities were located at Centro Regional de Investigación en
Salud Pública (CRISP), Tapachula, 15 km from the field site.
The protocol used in this study was similar to that used during
the previous OX3604C assessment in laboratory insectary condi-
tions [18]. Materials and methods were adapted to different
logistics and biosecurity conditions required for a field-cage
experiment. The most important differences between laboratory
and field-cage experiments are summarized in Table S1. Mexico
has a mature regulatory system for the use of genetically modified
organisms, having a law and implementing regulations in place
since 2005. Field cage experiments must comply with basic
biosafety procedures, oversight, and registration of all experimen-
tal procedures, installations and monitoring programs. Our
protocol was approved by the Mexican institutions Instituto
Nacional de Salud Pública (#581) and Secreterı́a de Medioam-
biente y Recursos Naturales (S.G.P.A./DGIRA/DG/7074/09).
Ethics statement
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of Laboratory
Animals of the National Institutes of Health. Protocols were
approved by the Institutional Animal Care and Use Committee of
the University of California, protocol 15653 [UCD] and the
Instituto Nacional de Salud Pública INSP Biosecurity permit #581
[CRISP].
Cage design
Our semi-field system consisted of six caging units each
measuring 66662 m (LxWxH) (Figure S1). A solid plastic roof
with sunscreen around the edges covered all six cages, and
provided shade and protection from direct sunlight. One caging
Author Summary
The absence of a commercially-available dengue vaccine
or anti-viral drug makes control of Aedes aegypti, the
principal dengue mosquito vector, the only available
method to prevent this disease. Sustained, effective
application of vector control, however, has been difficult
and this led to the call for innovative strategies, including
genetic approaches. Here, the authors investigated the
ability of a genetically-engineered strain of Ae. aegypti to
eliminate wild mosquito populations in large outdoor
cages. Females of the engineered strain cannot fly and,
therefore, cannot mate or take blood meals necessary to
lay viable eggs. Wild females that mate with genetically-
engineered males, therefore, will not produce reproductive
female offspring. In this study, although population
reductions were detected in 4 of 5 field cages, none of
the wild mosquito populations were eliminated. A mating
disadvantage for genetically-engineered males appeared
to account for a significant part of their fitness disadvan-
tage. Results suggest that this specific strain may not be
effective in a large-scale release and that new strains with
the same or similar transgene, but improved mating
performance, may be more effective for preventing
dengue. Results also indicate that large outdoor cage
experiments may provide valuable insights into the
progressive, stepwise assessment of genetically-engi-
neered mosquitoes.
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unit was used as a field laboratory for larval rearing and adult
mosquito handling. Each of the other five caging units was
divided in half by means of zippered mesh walls resulting in a
total of 10 66362 m cages (five pairs) (Figure S2). Each pair was
provided with two vestibules that allowed access to both cages
through three sleeves, two of which opened to shelves inside the
cage and a third opening to the cage floor (Figure S3). Cages
were made of white tricot mesh reinforced with white fabric and
located on a platform elevated 1 m above the ground, with ,3–
5 m between the top of each cage and the roof covering the
platform. Materials and general design used to build the cages is
described in detail by Facchinelli et al. [21]. Temperature and
relative humidity were measured by means of data-loggers (Hobo
Pro v2 temp/RH, Onset Computer Corporation, Bourne, MA),
located inside each cage and in the outdoor environment,
30 meters from the cages.
Biosecurity procedures
The protocol for field cage design, OX3604C colony mainte-
nance, and field cage experiments was approved by the Instituto
Nacional de Salud Pública (INSP) and Secretarı́a de Medio
Ambiente y Recursos Naturales (SEMARNAT), Mexico, under
the provisions of the law on genetically modified organisms (Ley de
Bioseguridad de Organismos Genéticamente Modificados, (Marzo
2005)). The field cage experiment protocol included procedures
for detection of potential escapes of OX3604C mosquitoes to the
open environment. Ten ovitraps and 10 BG-Sentinel Mosquito
Traps (Biogents AG, Regensburg, Germany) were distributed on
the ground around the cage platform. Three BG Sentinel Traps
were located inside the CRISP insectary where larvae were reared.
Ovitraps were serviced weekly and collected eggs were hatched
and larvae screened for the fluorescent marker. BG Sentinel Traps
were checked daily and Ae. aegypti adults were processed by gene
amplification (PCR) for transgene detection. No transgenic
mosquitoes were collected outside the field cages at the field site.
Two transgenic adults were collected by BG Sentinel Traps in the
room dedicated to OX3604C colony maintenance in the CRISP
insectary.
Mosquito strains
The OX3604C strain employed in this study was obtained by
backcrossing the homozygous OX3604C strain [17] into the
genetic background of the genetically-diverse laboratory strain #1
(GDLS1; [18]) derived from 10 geographically-distinct populations
collected during 2006 in Chiapas, Mexico [22]. Approximately
96.9% of the genome not linked to the transgene is expected to
consist of GDLS-derived sequences [18]. Before introducing
OX3604C into treatment cages, it was determined that the strain
was not homozygous for the transgene. Screening for the
fluorescent marker showed that the wild-type allele had a
frequency ranging between 4.7 and 8.7%. A mathematical model
indicated that at the release ratios we used, this low level of wild-
type alleles was not expected to significantly affect the outcome of
the experiment (Figure S4 and S5). Wild-type females were
removed prior to introducing OX3604C males into treatment
cages.
The target and control Ae. aegypti populations in our study were
the genetically-diverse laboratory strain #2 (GDLS2) derived from
2008 field collections in the same locations in Chiapas where
GDLS1 originated [18]. Aedes aegypti females were allowed to
imbibe blood directly from rabbits for colony maintenance, field
cage equilibration, and experiments (UC Davis Animal Care and
Use protocol 15653 and INSP Biosecurity permit #581).
Stabilization of target population
Target and control populations were established in each of the
10 experimental cages during a 16-week period using GDLS2
mosquitoes. Shelves inside each cage held (i) a total of four plastic
oviposition containers filled with ,600 ml sterilized water and
were lined with filter paper, (ii) four plastic larval development
containers filled with ,600 ml sterilized water and enclosed in a
mesh-covered dome to prevent oviposition, and (iii) four plastic
plates containing raisins as a source of sugar for adults (Figure S3).
Each cage also contained two humid, adult resting sites; i.e., 15 L
black plastic buckets that were lined with black fabric and
contained a mesh-covered water container.
GDLS2 eggs were hatched in Centro Regional de Investigación
en Salud Pública (CRISP) insectary and larvae transported to the
field site after 48 hours. Establishment of the target population was
initiated by adding 300 second-instar GDLS2 larvae weekly in
each cage from week 0 to week 3. Larvae were fed dried brewer’s
yeast ad libitum and females were fed blood from restrained rabbits
once a week for 30 minutes. From week 4 to week 16, the target
and control GDLS2 populations were maintained by returning
eggs laid by females in each cage to their respective cages as
second-instar larvae at a rate of 200/week. Eggs produced in cages
were collected twice a week and adults were sampled weekly to
monitor population dynamics. Eggs were transported to the
insectary, counted, dried and stored in a humidified chamber, and
then hatched for the next generation. Adults were sampled using
BG Sentinel Traps placed in each cage for 30 minutes each week,
counted, sexed after sedation on a CO2 sedation device (Figure
S6), and returned to their respective cage. Adult trapping and
handling resulted in 0–8% mortality. Cages were inspected at least
weekly for the presence of spiders, ants or other mosquito
predators. When arthropod predators were found they were
removed mechanically, without the use of insecticides. No
vertebrate predators were found during the 33-week period that
mosquitoes were in field cages.
Introduction of OX3604C
The lack of a homozygous OX3604C strain prevented us from
rearing and allowing OX3604C mosquitoes to emerge into
treatment cages as was performed by Wise de Valdez et al. [18].
Instead, pupae were sexed by visual examination for size at the
field laboratory insectary using 3 ml plastic droppers and only
adult males were added into treatment cages to avoid introducing
the few females lacking the transgene (,0.5%) that could have
interfered with population extinction. OX3604C eggs were
hatched weekly without tetracycline in the CRISP insectary,
second-instar larvae were transported to the field laboratory
insectary, placed in 35 plastic trays (each tray contained 500
larvae in 1.5 L of water) and fed dry ground yeast ad libitum.
Pupae were collected over the course of three days and sexed so
that a total of 5,250 male pupae were introduced into the five-
insectary cages (1,050 per 30630630 cm cage, taking into
account 5% mortality), which were held in the field laboratory
insectary. The sex of recently emerged adults was checked daily
by visual examination of adults in cages, females were removed,
and males were introduced into their respective treatment cages
every 24 h over the course of 4 days each week. The release
number remained constant. During the first OX3604C male
release [week 0 post-release], the release ratio was approximately
10 times the weekly return rate of 200 second-instar/GDLS2
larvae/week (i.e., approximately 100 GDLS2 males). Because the
mosquito population tended to decreased over time in the
treatment cages, the release ratio correspondingly increased from
10A1 OX3604CAtarget males during Week 0 post-release to
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between 14A1 to 1,000A1 during Week 17 post-release (Figure
S7). During Week 1 and 2 post-release, a total of 63 GDLS2
males from control cages and 50 OX3604C males that emerged
from rearing trays at the field site were collected to compare size
of the two strains. Right wing measurements were used to
determine mosquito body size.
Population maintenance post OX3604C introduction
Starting on week 0 post-release, a 10% sample of eggs produced
in each treatment cage was screened weekly for the DsRed2
marker to assess transgene introgression into target populations.
When the first fluorescent larvae were detected in treatment cages
confirming that OX3604C males were mating with GDLS2
females (week 3 post-release), the number of larvae added back to
each cage was adjusted to reflect the impact of the OX3604C male
release on egg production. Briefly, the number of larvae returned
to control cages remained constant at 200 second-instar larvae/
week, while the number of larvae added back to each treatment
cage was changed to a proportion of the egg number in the
respective paired control cage based on the procedures applied in
Wise de Valdez et al. [18]. At the end of our experiment, week 18
post-release, all mosquitoes present in the field cages were
collected with a backpack aspirator (John W. Hock Company,
23rd Ave, Gainesville, 32606 Florida, U.S.A.).
Mating competitiveness
A total of six mating competition experiments were carried out
between December 2010 and June 2011 with the aim of
investigating the lower performance of OX3604C in the field
cages trial versus the laboratory insectary trial [18].
Experiments 1, 2 and 3. Four insectary cages located at the
CRISP insectary (two 60660660 cm and two 30630630 cm),
and four cages located in the field laboratory (two 60660660 cm
and two 30630630 cm), were each populated with 10 GDLS2
females, 10 GDLS2 males and 10 OX3604C males, all 3–4 days
post adult eclosion. To populate the cages, virgin males were
introduced first, followed by females so that females had equal
opportunity to mate with GDLS2 or OX3604C males. This
procedure also was used during mating competition Experiments
4–6. Males and females were housed together for 24 hours after
which females were offered blood from rabbits for two consecutive
days. Each female was transferred into a mesh-screened plastic cup
lined with humid filter paper to stimulate oviposition. Eggs
collected from each female were conditioned and then hatched
at the CRISP insectary. Second- and third-instar larvae were
screened for DsRed2 marker fluorescence.
Experiment 4 (two replicates). Three 30630630 cm cages
housed in the field laboratory were each populated with 10
GDLS2 females, 10 GDLS2 males, and 10 OX3604C males. At
the same time, five large field cages that had been used in the
population reduction experiment were each populated with 100
GDLS2 females, 100 GDLS2 males, and 100 OX3604C males.
Males and females were housed together for 24 hours after which
females were offered blood from rabbits for two consecutive days.
All females from the small cages and 20 females from each large
field cage were transferred individually into a mesh-screened
plastic cup lined with humid filter paper to stimulate oviposition.
Eggs collected from each female were counted, conditioned and
then hatched at the CRISP insectary. Second- and third-instar
larvae were screened for fluorescence.
Experiment 5. Eight 30630630 cm cages, four located in
the field laboratory and, in a deviation from experiment 4, four
located in the CRISP insectary, were each populated with 10
GDLS2 females, 10 GDLS2 males, and 10 OX3604C males. At
the same time four large field cages were populated with 100
GDLS2 females, 100 GDLS2 males and 100 OX3604C males
each. Males and females were housed together for 24 hours after
which females were offered blood from rabbits for two consecutive
days. All females from the small cages and 20 females from the
large field cages were transferred individually into a mesh-screened
plastic cup lined with humid filter paper to stimulate oviposition.
Eggs collected from each female were counted, conditioned and
then hatched at CRISP insectary. Second- and third-instar larvae
were screened for fluorescence.
Experiment 6 (two replicates). Six large field cages were
used in two replicate experiments for three different treatments: (i)
two randomly-selected field cages were populated with 100
GDLS2 females and 100 GDLS2 males that were 3–4 days old
(young males and females) and 1,000 OX3604C males that were
10 days old (old males); (ii) two randomly-selected field cages were
populated with 100 GDLS2 females, 100 GDLS2 males, and
1,000 OX3604C males that were all 3–4 days old (young
mosquitoes); and (iii) two randomly-selected field cages were
populated with 100 GDLS2 females, 100 GDLS2 males, and
1,000 OX3604C males that were 9–10 days old (old mosquitoes).
Different aged males were used to explore possible effects of male
age during field cage experiments when GDLS males that were
released into field cage daily and OX3604C males that were
released only 3 days per week. Males and females were housed
together for 24 hours after which females were offered blood from
rabbits for two consecutive days. Thirty females were transferred
individually into a mesh-screened plastic cup lined with humid
filter paper to stimulate oviposition. Eggs collected from each
female were counted, conditioned and then hatched at CRISP
insectary. Second- and third-instar larvae were screened for
fluorescence
Statistical analysis
Main cage experiment. Distribution of eggs produced
weekly in cages was checked for normality using the Kolmo-
gorov-Smirnov test. Data were normalized by square-root
transformation prior to performing one-way analysis of covariance
(ANCOVA) to detect an OX3604C effect in treatment cages by
comparing weekly egg production in paired cages.
The Mann-Whitney U test was used to compare the number of
males collected in treatment cages with the number of males
collected in the respective paired control cages and the size of
OX3604C vs. GDLS2 males during the first 2 weeks of OX3604C
introduction in treatment cages.
Estimated fitness costs for OX3604C males in each treatment
cage were calculated by fitting the model [23] to field data (i.e.,
frequency of DsRed2 marker in larvae produced in treatment
cages, number of target larvae reintroduced weekly in each
treatment cage), using a nonlinear least squares procedure. To do
this, the mean of 1,000 simulations was fitted by minimizing the
sum of the squares of the residuals for the 15 weeks of DsRed2
frequency data for each cage. Simulations were run with the
following parameter values: baseline larval input for control
cages = 200; release ratio OX3604C:GDLS2 males = 10; daily
female survival probability = 0.90; daily male survival probabili-
ty = 0.72; mean daily number of offspring per female = 10. The
model assumes complete penetrance of the dominant flightless
trait. The estimated extinction time for each treatment cage was
calculated using the estimated fitness costs and 1,000 simulations
of the model [23] for each cage. The extinction time estimates
were calculated assuming the input of a 93.3% homozygous strain
to account for the average lack of homozgyosity observed in cage
experiments.
Field Cage Studies of Transgenic Mosquitoes
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Mating competitiveness experiments. A replicated G-
Test (Sokal and Rohlf 1995) was used to investigate if there was
an overall significant mating disadvantage to the OX3604C
strain in mating competitiveness experiments. To calculate
OX3604C mating disadvantage from mating competition exper-
iments, the number of GDLS2 batches was multiplied by
OX3604C:GDLS2 ratio to obtain expected number of
OX3604C egg batches. Then the actual number of OX3604C
batches was divided by the expected number to obtain a fractional
value for the fitness of the OX3604C males. The fractional value
for the fitness of the OX3604C males was subtracted from 1 to
estimate the mating disadvantage.
Results
Each of five caging units was partitioned into two paired cages
(pair A consists of cages 1 and 2, pair B consists of cage 3 and 4,
etc.) with dimensions of 66362 meters (LxWxH) (Figure S1 and
S2). Populations of the GDLS2 [18] were established in the ten
cages for a period of 16 weeks (from April to August 2010) prior to
the release of OX3604C males. Population densities stabilized in
all cages by week 9 (Figure 1). One cage in each pair was assigned
randomly during week 16 as a control or treatment cage (Figure
S2). From week 16 to week 33 (from 16 August to 23 December
2010), corresponding to week 0 through week 17 post-release,
,1,000 OX3604C males were introduced weekly into each
treatment cage. This number corresponds to an approximate
initial 10:1 OX3604C:GDLS2 male release ratio (Figure S7). The
constant release number of OX3604C males, calculated to
establish the initial 10:1 ratio based on input rate by the average
lifespan, was maintained from week 0 to week 17 post-release.
When transgene introgression into the caged populations was first
detected (presence of the DsRed2 marker gene in larvae), during
week 3 post-release (Figure 2), the weekly number of larvae
returned to each treatment cage was adjusted relative to the
weekly return rate in the respective paired control cage (held
constant at 200 second-instar larvae/week in all control cages).
This was done to reflect any impact of OX3604C male release on
egg production by females in each treatment cage. Based on the
number of larvae returned to treatment cages from week 3 to week
17 post-release, release ratios of OX3604C:target males increased
in all treatment cages reaching the highest value of 1,000:1 in cage
1 during week 17 post-release (Figure S7).
Temperatures during the trial ranged between 14.5uC and
41.8uC in all cages except cage 6 where a peak of 44.2uC was
recorded on 27 April (Table S2). During the rest of the trial,
temperatures in cage 6 were similar to those recorded in the other
field cages. Daily temperature fluctuations ranged between 2.0uC
and 20.7uC. Relative humidity (RH) in field cages ranged from
38.1% during the warmer hours of the day to 99.4% at dawn.
Temperatures recorded outside of the cages were similar to those
recorded in cages and ranged from 15.8uC to 40.7uC. RH outside of
cages also was similar to that recorded inside cages, ranging from
42.8% to 100% with a mean of 89.2%611.6% (SD) (Table S2).
Weekly adult sampling performed the day before starting the
next OX3604C release into treatment cages confirmed the
presence of a significantly higher number of males in treatment
cages compared to their respective control cages (Mann-Whitney
U test p,0.01 for all cage units) (Figure 3). The percentage of
DsRed2 larvae produced in treatment cages fluctuated between 1
and 76% but never reached 100% (Figure 2).
ANCOVA indicated that the number of eggs produced in
treatment cages decreased significantly subsequent to male
OX3604C release compared to respective paired control cages
in all treatment cages except cage 4, where covariates did not
indicate an effect (Figure 4). Ratios of females collected in control
Figure 1. Egg production in treatment and control cages. Weekly egg production is shown for each control and treatment cage. Production
numbers were stable in all cages by week 9 after population establishment. After OX3604C male release was initiated (vertical dashed line) in the
treatment cages (week 16; week 0 PR, top time axis), egg production in the control cages continued to be stable and declined slightly in the
treatment cages.
doi:10.1371/journal.pntd.0002001.g001
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vs. treatment cages per each cage unit matched results of
ANCOVA (F) (Table S3; Figure 4), being highest in pair A and
lowest in pair B, following the same ranking (i.e., pairs A, E, D, C,
B from highest to lowest values).
No extinction, defined as two weeks without eggs collected in
oviposition containers and no adult females collected with BG-
Sentinel Mosquito Traps was detected in any treatment cage
during the 17 weeks post-release. The low effectiveness of the
OX3604C strain in all treatment cages is supported by high
OX3604C fitness cost estimates calculated with a simulation
model for each treatment cage (Table 1). Model predictions based
on extrapolation from the 17 weeks of data indicate that
Figure 2. Progeny genotypes in treatment cages. A random sample of eggs from each treatment cage collected weekly was hatched and
screened for the DsRed2 marker starting from Week 0 post-release. The number of screened larvae corresponded to 10% of the eggs produced
weekly per cage or a minimum of two hundred, when available.
doi:10.1371/journal.pntd.0002001.g002
Figure 3. Adult males sampled weekly with BG Sentinel Traps. Each week, adult sampling was performed the day before the weekly release
of OX3604C males. Significantly higher numbers of males were collected in treatment cages with respect to control cages (Table S3) starting from
Week 2 post-release (PR), indicating that transgenic males were present in large numbers over time in release cages.
doi:10.1371/journal.pntd.0002001.g003
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mosquitoes in all but one cage had at most an 11% chance of
extinction within 10 weeks from the day the field cage experiment
was terminated (probability of extinction for cage 1 was 0.36). On
average, predicted extinction times for cages ranged between week
23 and week 65 post-release (Table 2).
Results of mating competition experiments are summarized in
Table 3. Mating competition experiments 1–5, which all used a
1:1 OX3604C:GDLS2 ratio, but varied in cage size and location,
produced variable results as indicated by the significant hetero-
geneity statistic in the replicated G-test (Het. G = 38.04, p,0.01;
see Table S4). However, even with this heterogeneity value, the
pooled G-value (4.124) is significant (p = 0.042) and indicates a
mean mating fitness cost of 10.8% for the OX3604C males (Table
S4). Experiment 6 was designed to better reflect conditions in the
field cage experiment with a 10:1 OX3604C:GDLS2 ratio and the
same cages and initial density as the long-term experiments.
Results of the replicates also were variable (Het. G = 20.72,
p = 0.04) and the overall difference between the strains was
significant (Pooled G = 43,83, p,0.01) with a mean mating fitness
cost of 59.1% for OX3604C males (Table S4).
Discussion
OX3604C males decreased, but did not eliminate target
populations in the field-cage experiment. Experimental protocols
were similar between the previous laboratory experiment [18] and
our field cage experiment, including high 10:1 release ratios that in
both cases were expected, based on modeling, to favor popula-
Figure 4. ANCOVA results for egg production dynamics in paired cages A, B, C, D, and E.
doi:10.1371/journal.pntd.0002001.g004
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tion extinction. Over the course of the field cage study, the
OX3604C:target male ratio increased in all cages and reached the
highest value of 1,000:1 in cage 1 during week 17 post-release, but
this did not result in extinction of the target population. These
results also were consistent with the data on the frequency of the
DsRed2 marker detected in larvae from treatment cages, which
ranged from 20–54% during week 17 post-release when the trial
was terminated. The high estimated OX3604C male fitness cost
calculated from the field cage trial (97%), the lower than predicted
population reduction, and the long estimated extinction times
(average 23–65 weeks) lead to the expectation that male
OX3604C may be less effective for population reduction under
open field conditions than predicted from results of the laboratory
cage experiment.
Output from a simulation model predicted that the lack of a
homozygous OX3604C strain did not contribute significantly to
the absence of population extinction, because of the high
OX3604C:target male release ratio. Presence of wild-type
individuals in the transgenic population required that we manually
sex pupae in order to avoid introducing wild-type females into
treatment cages. This resulted in a difference in management of
the transgenic strain relative to the target strain and relative to the
handling of the transgenic strain by Wise de Valdez et al [18]. The
mortality observed among the transgenic males before introduc-
tion into treatment cages was low (,5%), suggesting that this
additional handling did not cause substantial harm. Furthermore,
transgenic male survival in the cages was high. As can be seen in
Figure 3, there were on average about 5 times as many males in
treatment cages as control cages on day six after each release of
OX3604C. This is equivalent to a daily survival rate of ,0.91,
which is similar to published values for Ae. aegypti survival in houses
in the field [24]. The potential effect of differential handling was
not addressed directly by the mating competitiveness experiments
because the need to separate males from females added an
additional handling step for GDLS2 males and females, such that
the treatment of the two types was matched more closely in these
experiments than in the earlier field cage experiment. Because
differences were not apparent in the field cage trial, male survival
was not evaluated in mating competitiveness experiments.
Mosquito size is sometimes but not always [25] associated with
fitness. For Ae. aegypti, Ponlawat and Harrington [26] reported
greater mating success by larger than smaller males. Measure-
ments made in the first two weeks of the field cage experiment
indicated that OX3604C males (median wing length = 2.24) were
slightly larger than GDLS2 males (median wing length = 2.17,
Mann-Whitney U test p,0.01), so this is unlikely to have
contributed to the field cage outcomes.
Results from mating competitiveness experiments with labora-
tory-reared mosquitoes in field cages have generally been found
to underestimate fitness costs found when the same types of
mosquitoes are released in the field [27–29]. While the mating
disadvantage of OX3604C males observed in experiment 6
(59.1%) appears to be one factor explaining the lack of extinction
in our field cage trial, if there had only been a fitness cost of 59%,
some extinctions would have been expected (Figures S4, S5).
Therefore, although short-term mating competitiveness experi-
ments are useful in assessing one major component of fitness, they
are not designed to measure as many aspects of fitness as are
measured in long-term studies.
Adaptation of genetically-engineered mosquitoes and target
populations to laboratory and field cages always needs to be taken
into account when moving from the laboratory to the field. In the
field cage trial, OX3604C was derived from introgression of the
OX3604C construct into a GDLS1 genetic background, reared in
laboratory conditions (i.e., stable temperature, relative humidity,
and photoperiod) and mated in small, crowded laboratory cages
Table 1. OX3604C fitness cost estimates during the field cage
trial per treatment cage.








1Sum of square errors associated with each estimate.
2Standard deviation.
doi:10.1371/journal.pntd.0002001.t001
Table 2. Extinction time estimated per each treatment cage assuming the estimated fitness costs from Table 1.
Cage Minimum1 Maximum2 Mean3 SD4
Probability
of Extinction
in Weeks 18–28 PR5
1 20 53 29.9 4.515 0.36
4 21 54 35.0 5.722 0.11
6 27 78 43.6 7.830 0.01
7 24 65 36.1 5.664 0.05
10 24 74 40.4 7.105 0.03
Mean 23.2 64.8 37.0





5Probability of observing extinction between weeks 18–28 PR, obtained from the outcomes of 1000 simulated experiments.
doi:10.1371/journal.pntd.0002001.t002
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for more than 20 generations, all of which potentially selected for
capacity to mate in a small spaces, and other adaptations for
increased fitness in a laboratory environment. Conversely, GDLS2
originated from mosquitoes collected from the same locations 2
years after those used to create GDLS1, and GDLS2 target
populations were maintained in large outdoor field cages for 16
generations before the start of the experiment. During the
prerelease period, GDLS2 populations experienced natural
variation in daily temperature and relative humidity and mated
successfully for ,4 months in their large outdoor enclosures.
Adaptation to field cages may have been an advantage for GDLS2
males when competing with OX3604C males for GDLS2 females.
Our results are consistent with those from previous mosquito studies
[27,28,30] indicating that colony maintenance and mass rearing
should be planned prior to field-cage or open-field trials. Rearing large
numbers of transgenic mosquitoes in large outdoor, semi-field
enclosures for several generations may help avoid undesirable
laboratory adaptation and reduce fitness differences between trans-
genic mosquitoes and conspecifics in their natural, target populations.
Short-term mating competition experiments in large field cages could
be an efficient way to gather preliminary information on genetically-
engineered mosquito fitness relative to local wild-type mosquitoes, but
they only measure one important fitness component while field cage
trials include additional components.
We emphasize the potential impact of differential strain
adaptation to the field or laboratory, but it is also possible that
the fitness difference was due to the transgenesis process. Although
insertion of the transgene did not affect the ability of the
OX3604C to cause extinction in the laboratory system, it is
feasible that some negative pleiotropic effect of the gene insertion
was manifested only under field cage conditions. Precautions were
taken to avoid some negative effects that are often associated with
transgenesis. Most importantly, the originally engineered strain
was backcrossed for five generations to a strain for the local area
where the experiment was conducted. This was expected to
replace over 96% of the genes from the engineered strain with
local strain genes, except for genes linked to the transgene. If the
transgene had been inserted within a transcribed gene, it could
have disrupted gene function that affected fitness in outdoor field
cages, but not in the laboratory. Attempts to fine-scale map the
location of the transgene indicated that the insertion was in a
genomic area with repetitive DNA, indicating the transgene was
not inserted within a transcribed gene.
Although an argument can be made for not pursuing an open
field evaluation of OX3604C males based on our field cage
results, the best way to resolve the discrepancy between
laboratory and field cage results would be to assess them under
uncontained, open field conditions. Because this has not been
done, data do not exist to determine whether laboratory or field
cage experiments are most informative about how this strain will
perform under natural conditions. A different genetic back-
ground, different chromosomal location of the transgene or
different rearing procedures could separately or in combination
affect the competitiveness of transgenic mosquitoes. Evaluation of
other Ae. aegypti strains carrying the female-flightless transgene
would help determine if results observed in this trial apply to this
genetic modification in general or are specific to the OX3604C
strain we studied.
Our results support inclusion of large outdoor field cage
experiments in the systematic, phased evaluation of GE Ae. aegypti,
including those with transgenes like OX3604C that are self-
limiting. Details of field cage construction and the level of
containment needed will depend on the nature of genetic
modification in the strain being evaluated as well as general
requirements of the relevant regulatory authorities. If genetic
modifications include the potential of elevated pathogen trans-
mission or non-Mendelian inheritance (i.e., genetic drive systems),
strain evaluation will require higher security caging than those
used in our experiments [20]. We stress that short-term mating
competition experiments in large field cages could be used to
obtain predictive information on mating competitiveness and
fitness costs, but it is not clear that by themselves these would be
sufficient substitutes for longer-term field cage tests. Results of
appropriately planned, executed and analyzed open-field releases
of the OX3604C would be useful in addressing this issue.
All of the work described here was conducted within ethical,
social and cultural guidelines for community engagement
activities [16]. We found that this approach helped us to develop
respect and trust, basic ingredients for strong working relation-
ships with local residents living near the field site, and for
appropriate dialogue with state and national health and
environmental authorities, scientists, and local and international
press. Although the containment measures and communication
activities taken in this work were greater than expected for
research with natural strains of mosquitoes, we feel that this
precautionary approach could have long-term benefits by
decreasing suspicion that transgenic mosquito technology is being
applied carelessly [31].
Supporting Information
Figure S1 Picture of the field cages.
(PDF)
Figure S2 Diagram of the field cage set up. The
OX3604C strain was reared in trays in the field laboratory (lower
right). When adult males emerged they were moved to their
corresponding treatment cage. Adults were sampled in cages using
BG Sentinel Traps, transferred to the field laboratory, anesthe-
tized in the CO2 sedation device, counted, sexed, and returned to
the cage from which they came. For biosecurity, 10 BG Sentinel
Traps and 10 oviposition traps were located around and below the
platform, respectively.
(PNG)
Figure S3 Each half cage contained two cabinets. The top
two shelves of each cabinet held two larval rearing containers
covered by screened domes that prevented females from laying eggs
(denoted by 1) and two oviposition containers (denoted by 2). A 15 L
black plastic bucket partially covered with black plastic providing a
sheltered and humid refugee (denoted by 3) and two plates with
raisins (denoted by 4) provided a sugar source for adults.
(PNG)
Figure S4 Simulated cage dynamics for varying combi-
nations of percent homozygosity and fitness costs.
Heterozygotes have K of the fitness cost as homozygotes, and
the fitness cost is assumed to occur at mating time. (Top)
Simulated dynamics of eggs throughout the 17 week release
period. (Bottom) Genotype frequency of OX3604C throughout
the 17 week release period. Fitness costs are (a) 90%, (b) 80%, (c)
70%, and (d) 60%. Percentages of homozygosity are 100%
(circles), 90% (squares), and 80% (triangles).
(PNG)
Figure S5 Histograms of post-release extinction times,
given in weeks, predicted by the model for different
combinations of fitness costs and percent homozygosity.
Each row represents a different fitness cost while each column
represents a different percentage of homozygosity. Heterozygotes
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have K of the fitness cost as homozygotes, and the fitness cost is
assumed to occur at mating time.
(PNG)
Figure S6 Device developed and used for mosquito
sedation at the field site. (A) There were four mesh-screened
chambers, each accessible through two sleeved openings in the
side of the table. (B) Carbon dioxide from a 40 L tank was
regulated by a manometer and (C) its flow was piped into four
screened containers, each one located in one of the four chambers.
(D) Sedated mosquitoes were transferred to the mesh lid, counted,
sexed, and returned to the cup and then to the field cage from
which they came.
(PNG)
Figure S7 Release ratios of OX3604C:target males over
time (log transformed data). Ratios were estimated based on
the number of OX3604C males added weekly to treatment cages
and the weekly larval return rate.
(PNG)
Table S1 Summary of differences between laboratory
(Wise de Valdez et al. [18]) and field cage experiments
near Tapachula, Mexico.
(PNG)
Table S2 Mean temperatures (±SD), maximum and
minimum temperature, maximum and minimum daily
temperature range, mean RH (±SD), and maximum and
minimum RH recorded inside field cages and in a field
outside of the cages.
(PNG)
Table S3 Number of adults collected with backpack
aspirators in field cages when the experiment was
terminated on week 17 PR and the ratio of females
collected in control vs. treatment cages for each pair of
cages.
(PNG)
Table S4 Total fitness cost (1-geometric mean of
observed/expected OX3604C), calculated for mating
competition experiments 1–5 and 6.
(PNG)
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